Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy

Abroad (travel likely)RecruitingPHASE1

Conditions

Dilated Cardiomyopathy (DCM) · Heart Failure

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang / 浙江, China
Contact: Study coordinator (Jiamin Li, Dr) · 21818216@zju.edu.cn · 18868112006
Study coordinator · 21818216@zju.edu.cn

Study leads

Xinyang Hu, PhD
Principal Investigator
Second Affiliated Hospital, School of Medicine, Zhejiang University, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy

Dilated Cardiomyopathy (DCM) · Heart Failure

Abroad (travel likely)RecruitingPHASE1, PHASE2

Hangzhou, China

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

Ventricular Ejection Fraction · LVF · LV Dysfunction

Abroad (travel likely)Recruiting

Orange, United States · Pasadena, United States

Study of the Progression of Chronic Cardiovascular Conditions

Cardiovascular Disease (CVD) · Heart Failure · Aortic Stenosis

Abroad (travel likely)Recruiting

Chicago, United States

UIC Multi-Ethnic DCM Registry

Heart Failure · Dilated Cardiomyopathy (DCM)

Abroad (travel likely)Recruiting

Chicago, United States